We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
-$14.1B
Cap. Flow
-$21.4B
Cap. Flow %
-17.01%
Top 10 Hldgs %
26.03%
Holding
6,223
New
309
Increased
1,914
Reduced
2,674
Closed
469

Sector Composition

Rank Sector Weight
1 Technology 9.68%
2 Healthcare 6.62%
3 Financials 5.53%
4 Consumer Discretionary 5.08%
5 Industrials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDTX icon
5376
Black Diamond Therapeutics
BDTX
$99.1M
$243 ﹤0.01%
135
-438
-76% -$789
ROOT icon
5377
Root
ROOT
$944M
$242 ﹤0.01%
54
-180
-77% -$1.24K
CIX icon
5378
Comp X International
CIX
$342M
$240 ﹤0.01%
13
-193
-94% -$3.59K
IMPL
5379
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$240 ﹤0.01%
64
-281
-81% -$1.02K
DCFCW
5380
CALL
DELISTED
Tritium DCFC Limited Warrant
DCFCW
$237 ﹤0.01%
833
SLS icon
5381
SELLAS Life Sciences
SLS
$2.13B
$236 ﹤0.01%
+100
New +$280
IGRO icon
5382
iShares International Dividend Growth ETF
IGRO
$1.28B
$231 ﹤0.01%
4
+2
+100% +$110
TRML
5383
DELISTED
Tourmaline Bio
TRML
$231 ﹤0.01%
23
-68
-75% -$1.09K
BRDS
5384
DELISTED
Bird Global, Inc.
BRDS
$231 ﹤0.01%
51
-53
-51% -$389
RUBY
5385
DELISTED
Rubius Therapeutics, Inc
RUBY
$231 ﹤0.01%
1,342
+56
+4% +$15
COOLW
5386
CALL
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$230 ﹤0.01%
+7,634
New +$216
APLT
5387
DELISTED
Applied Therapeutics
APLT
$223 ﹤0.01%
293
-101,652
-100% -$80.4K
JOAN
5388
DELISTED
JOANN, Inc. Common Stock
JOAN
$217 ﹤0.01%
76
-93
-55% -$439
DAO
5389
Youdao
DAO
$1.91B
$215 ﹤0.01%
40
QDROW
5390
CALL
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$215 ﹤0.01%
33,334
OPAD icon
5391
Offerpad Solutions
OPAD
$20.1M
$211 ﹤0.01%
3
-13
-81% -$1.5K
SUNL
5392
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$210 ﹤0.01%
8
-10
-56% -$277
TBIO
5393
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$205 ﹤0.01%
9
-19
-68% -$516
IPHA
5394
Innate Pharma
IPHA
$166M
$201 ﹤0.01%
54
BGRY
5395
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$200 ﹤0.01%
332
-406
-55% -$454
SLNO
5396
DELISTED
Soleno Therapeutics
SLNO
$198 ﹤0.01%
+100
New +$124
TBSAW
5397
CALL
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$196 ﹤0.01%
+8,334
New +$348
MKTW icon
5398
MarketWise
MKTW
$54.4M
$195 ﹤0.01%
6
-7
-54% -$304
OPFI icon
5399
OppFi
OPFI
$804M
$195 ﹤0.01%
95
-131
-58% -$295
ATIP
5400
DELISTED
ATI Physical Therapy, Inc.
ATIP
$189 ﹤0.01%
12
-103
-90% -$3.47K

Similar funds

Citigroup's Q4 2022 Portfolio in Review

As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.

  • Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
  • Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
  • Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
  • Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
  • Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
  • Citigroup opened 309 new positions and closed 469 in Q4 2022.
  • Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.